GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CLS Holdings USA Inc (XCNQ:CLSH) » Definitions » Capex-to-Operating-Cash-Flow

CLS Holdings USA (XCNQ:CLSH) Capex-to-Operating-Cash-Flow : 0.00 (As of Feb. 2024)


View and export this data going back to 2019. Start your Free Trial

What is CLS Holdings USA Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

CLS Holdings USA's Capital Expenditure for the three months ended in Feb. 2024 was C$0.02 Mil. Its Cash Flow from Operations for the three months ended in Feb. 2024 was C$-0.56 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


CLS Holdings USA Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for CLS Holdings USA's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CLS Holdings USA Capex-to-Operating-Cash-Flow Chart

CLS Holdings USA Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
Capex-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

CLS Holdings USA Quarterly Data
May19 Aug19 Nov19 Feb20 May20 Aug20 Nov20 Feb21 May21 Aug21 Nov21 Feb22 May22 Aug22 Nov22 Feb23 May23 Aug23 Nov23 Feb24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 0.10 0.11 -

Competitive Comparison of CLS Holdings USA's Capex-to-Operating-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, CLS Holdings USA's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CLS Holdings USA's Capex-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CLS Holdings USA's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CLS Holdings USA's Capex-to-Operating-Cash-Flow falls into.



CLS Holdings USA Capex-to-Operating-Cash-Flow Calculation

CLS Holdings USA's Capex-to-Operating-Cash-Flow for the fiscal year that ended in May. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (-0.205) / -0.311
=N/A

CLS Holdings USA's Capex-to-Operating-Cash-Flow for the quarter that ended in Feb. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0.016) / -0.562
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CLS Holdings USA  (XCNQ:CLSH) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


CLS Holdings USA Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of CLS Holdings USA's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


CLS Holdings USA (XCNQ:CLSH) Business Description

Traded in Other Exchanges
Address
1800 Industrial Road, Suite 100, Las Vegas, NV, USA, 89102
CLS Holdings USA Inc is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada and plans to expand to other states. CLS stands for Cannabis Life Sciences in recognition of the company's patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The company's business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services. The company generates the majority of its revenues and corresponding accounts receivable from the sale of cannabis, and cannabis related products.